Modulation of Tumor Development by Butylated Hydroxytoluene in Experimental Animals

Babich H. 1982. Butylated hydroxytoluene (BHT): A review. Environ. Res. 29: 1–29.

Barbolt T.A. , and Abraham R. 1979. Lack of effect of butylated hydroxytoluene on dimethylhydrazine-induced colon carcinogenesis in rats. Experientia 35: 257–258.

Blumenthal H. 1986. Panel discussion II. Risk assessment associated with the use of phenolic antioxidants in food. Fd. Chem. Toxic. 24: 1243–1253.

Bolton J.L. , Sevestre H. , Ibe B.O. , and Thompson J.A. 1990. Formation and reactivity of alternative quinone methides from butylated hydroxytoluene: possible explanation for species-specific pneumotoxicity. Chem. Res. in Toxicol. 3: 65–70.

Bolton J.L. , and Thompson J.A. 1991. Oxidation of butylated hydroxytoluene to toxic metabolites. Factors influencing hydroxylation and quinone methide formation by hepatic and pulmonary microsomes. Drug Metabolism and Disposition 19: 467–472.

Clapp N.K. , Bowles N.D. , Satterfield L.C. , and Klima W.C. 1979. Selective protective effect of butylated hydroxytoluene against 1,2-dimethylhydrazine carcinogenesis in BALB/c mice. JNCI 63: 1081–1085.

Cohen L.A. , Polansky M. , Furuya K. , Reddy M. , Berke H. , and Weisburger J.K. 1982. Inhibition of chemically induced mammary carcinogenesis in rats by short-term exposure to butylated hydroxytoluene (BHT): Interrelationships between BHT concentration, carcinogen dose, and diet. JNCI 72: 165–173.

Daoud A.H. , and Griffin A.C. 1980. Effect of retinoic acid, butylated hydroxytoluene, selenium and sorbic acid on azo-dye hepatocarcinogenesis. Cancer Letters 9: 299–304.

Fukushima S. , Sakata T. , Tagawa Y. , Shibata M.A. , Hirose M. , and Ito N. 1987a. Different modifying response of butylated hydroxyanisole, butylated hydroxytoluene and other antioxidants in N, N-Dibutylnitrosamine esophagus and forestomach carcinogenesis of rats. Cancer Res. 47: 2113–2116.

Fukushima S. , Ogiso T. , Kurata Y. , Hirose M. , and Ito N. 1987b. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl) nitrosamine initiated, unilaterally ureter ligated rats. Cancer Letters 34: 83–90.

Grice H.G. 1986. Food antioxidants: International Perspectives. Fd. Chem. Toxic. Vol. 24.

Hirose M. , Shibata M. , Hagiwara A. , Imaida K. , and Ito N. 1981. Chronic toxicity of butylated hydroxytoluene in Wistar rats. Fd. Cosmet. Toxicol. 19: 147–151.

Imaida K. , Fukushima S. , Shirai T. , Ohtani M. , Nakanishi K. , and Ito N. 1983. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci in the liver of rats. Carcinogenesis 7: 896–899.

Imaida K. , Kukushima S. , Shirai T. , Masui T. , Ogiso T. , and Ito N. 1984. Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium L-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in male rats. Gann 75: 769–755.

Imaida K. , Fukushima S. , Inoue K. , Masui T. , Hirose M. , Ito N. 1988. Modifying effects of concomitant treatment with butylated hydroxyanisole or butylated hydroxytoluene on N, N-dibutylnitrosamine-induced liver, forestomach and urinary bladder carcinogenesis in F344 male rats. Cancer Letters 43: 167–172.

Ito N. , Fukushima S. , and Tsuda H. 1985. Carcinogenicity and modification of the carcinogenic response by BHA, BHT and other antioxidants. CRC Crit. Rev. Toxicol. 15: 109–150.

Ito N. , Hirose M. , Fukushima S. , Tsuda H. , Shirai T. , and Tatematsu M. 1986. Studies on antioxidants: their carcinogenic and modifying effects on chemical carcinogenesis. Fd. Chem. Toxic. 24: 1071–1082.

Kahl R. 1984. Synthetic antioxidants: Biochemical actions and interference with radiation, toxic compounds, chemical mutagens and chemical carcinogens. Toxicology 33: 185–228.

King M.M. , Bailey D.M. , Gibson D.G. , Pitha J.V. , and McCay P. 1979. Incidence and growth of mammary tumors induced by 7,12-dimethylbenz(a)anthracene as related to dietary content of fat and antioxidant. JNCI 63: 657–663.

King M.M. , McCay P.B. , and Kosanke S.D. 1981. Comparison of the effect of butylated hydroxytoluene on N-nitrosomethylurea and 7,12-Dimethylbenz(a)anthracene-induced mammary tumors. Cancer Letters 14: 219–226.

Lindenschmidt R.C. , Tryka A.F. , Goad M.E. , and Witschi H.P. 1986. The effects of dietary butylated hydroxytoluene on liver and colon tumor development in mice. Toxicology 38: 151–160.

Lindenschmidt R.C. , Tryka A.F. , and Witschi H.P. 1987. Modification of gastrointestinal tumor development in rats by dietary butylated hydroxytoluene. Fundam. Appl. Toxicol. 8: 474–481.

Maeura Y. , and Williams G.M. 1984. Enhancing effect of butylated hydroxytoluene on the development of liver altered foci and neoplasms induced by N-2-fluorenylacetamide in rats. Fd. Chem. Toxic. 22: 191–198.

Maeura Y. , Weisburger J.H. , and Williams G.M. 1984. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene. Cancer Res. 44: 1604–1610.

Malkinson A.M. 1983. Review: Putative mutagens and carcinogens in foods. III. Butylated hydroxytoluene (BHT). Environ. Mutagenesis 5: 353–362.

Malkinson A.M. 1985. Multiple modulatory effects of butylated hydroxytoluene on tumorigenesis. Cancer Invest. 3: 209–211.

Malkinson A.M. 1989. The genetic basis of susceptibility to lung tumors in mice. Toxicology 54: 241–271.

Maru G.B. , and Bhide S.V. 1982. Effect of antioxidants and antitoxicants of isoniazid on the formation of lung tumors in mice by isoniazid and hydrazine sulfate. Cancer Letters 17: 75–80.

McCormick D.L. , Major N. , and Moon R.C. 1984. Inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis by concomitant or postcarcinogenic antioxidant exposure. Cancer Res. 44: 2855–2863.

Moore M.A. , Thamavit M. , Tsuda H. , and Ito N. 1986. The influence of subsequent dehydroepiandrosterone, diaminopropane, phenobarbital, butylated hydroxyanisole and butylated hydroxytoluene treatment on the development of preneoplastic and neoplastic lesions in the rat initiated with di-hydroxy-di-N-propyl nitrosamine. Cancer Letters 30: 153–160.

Nih 1979. Bioassay of butylated hydroxytoluene (BHT) for possible carcinogenicity. NCI-CG-TR-159 (NIH publication No. 79-1706). US Department of Health, Education and Welfare, Public Health Service.

Peraino C. , Fry R.J.M. , Staffeldt E. , and Christopher J.P. 1977. Enhancing effects by phenobarbitone and butylated hydroxytoluene on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Fd. Cosmet. Toxicol. 15: 93–96.

Roebuck B.D. , MacMillan D.L. , Bush D.M. , and Kensler T.W. 1984. Modification of azaserine-induced pancreatic foci by phenolic antioxidants in rats. JNCI 72: 1405–1409.

Shirai T. , Hagiwara A. , Kurata Y. , Shibata S. , Fukushima S. , and Ito N. 1982. Lack of carcinogenicity of butylated hydroxytoluene on long-term administration of B6C3F1 mice. Fd. Chem. Toxic. 20: 861–865.

Shirai T. , Fukushima S. , Ohshima M. , Masuda A. , and Ito N. 1984. Effects of butylated hydroxyanisole, butylated hydroxytoluene and NaCl on gastric carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine in F344 rats. JNCI 72: 1189–1198.

Shirai T. , Ikawa E. , Hirose M. , Thamavit W. , and Ito N. 1985. Modification by five antioxidants of 1,2,-dimethylhydrazine-initiated colon carcinogenesis in F344 rats. Carcinogenesis 6: 637–639.

Stoner G.D. , Shimkin M.B. , Kniazeff A.J. , Weisburger J.H. , Weisburger E.K. , and Gori G.B. 1973. Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice. Cancer Res. 33: 3069–3085.

Takahashi M. , Furukawa F. , Toyoda K. , Sato H. , Hasegawa R. , and Hayashi Y. 1986. Effects of four antioxidants on methyl-N'-nitro-N-nitrosoguanidine initiated gastric tumor development in rats. Cancer Letters 30: 161–168.

Tatsuta M , Mikuni T. , Taniguchi H. 1983. Protective effect of butylated hydroxytoluene against induction of gastric cancer by N-methyl-N'-nitrosoguanidine in Wistar rats. Int. J. Cancer 32: 253–254.

Thompson J.A. , Bolton J.L. , and Malkinson A.M. 1991. Relationship between the metabolism of butylated hydroxytoluene (BHT) and lung tumor promotion in mice. Exp. Lung Res. 17: 439–453.

Thornton M. , Moore A.M. , and Ito N. 1989. Modifying influence of dehydroepiandrosterone or butylated hydroxytoluene treatment on initiation and development stages of azaserine-induced acinar pancreatic preneoplastic lesions in the rat. Carcinogenesis 10: 407–410.

Ulland B.M. , Weisburger J.H. , Yamamoto R.S. , and Weisburger E.K. 1973. Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamide, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats. Food Cosmet. Toxicol. 11: 199–207.

Wattenberg L.W. 1973. Inhibition of carcinogenesis and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. JNCI 48: 1425–1430.

Wattenberg L.W. 1980. Inhibition of chemical carcinogenesis by antioxidants. In: Modifiers of chemical carcinogenesis: An approach to biochemical mechanisms and cancer prevention ( Slaga T.J. ed.). Raven Press, New York.

Weisburger E.K. , Evarts R.P. , and Wenk M.L. 1977. Inhibitory effect of butylated hydroxytoluene (BHT) on intestinal carcinogenesis in rats by azoxymethane. Fd. Cosmet. Toxicol. 15: 139–141.

Williams G.M. , Maeura Y. , and Weisburger J.H. 1983. Simultaneous inhibition of liver carcinogenicity and enhancement of bladder carcinogenicity of N-2-fluorenylacetamide by butylated hydroxytoluene. Cancer Letters 19: 55–60.

Witschi H.P. 1981. Enhancement of tumor formation in mouse lung by dietary butylated hydroxytoluene. Toxicology 21: 95–104.

Witschi H.P. 1985. Enhancement of lung tumor formation in mice. In: Cancer of the Respiratory Tract, Mass M.J. , Kaufman D.G. , Siegfried J.M. , Steele V.E. , Nesnow S. (eds.). Vol. 8 Carcinogenesis, A Comprehensive Survey, Raven Press, N.Y., pp. 147–158.

Witschi H.P. 1986. Separation of early diffuse alveolar cell proliferation from enhanced tumor development in mouse lung. Cancer Res. 46: 2675–2679.

Witschi H.P. , and Morse C.C. 1983. Enhancement of lung tumor formation in mice by dietary butylated hydroxytoluene: Dose-time relationships and cell kinetics. JNCI 71: 859–866.

Witschi H.P. , Williamson D. , and Lock S. 1977. Enhancement of urethan tumorigenesis in mouse lung by butylated hydroxytoluene. J. Natl. Cancer Inst. 58: 301–305.

Witschi H.P. , Malkinson A.M. , and Thompson J.A. 1989. Metabolism and Pulmonary Toxicity of Butylated Hydroxytoluene (BHT). Pharmac. Ther. 42: 89–113.

Wurtzen G. , and Olsen P. 1986. Chronic study on BHT in rats. Fd. Chem. Toxic. 24: 1121–1125.